What happens when healthcare organisations skip regular security control validation?

What regular validation is actually proving

security control are only useful when they still work in the environment they are meant to protect. Regular validation checks whether detective, preventive, and corrective controls are still configured correctly, still producing the expected signal, and still covering the systems that matter, including high-value clinical applications, connected devices, and shared infrastructure.

In healthcare, that matters because control drift is common. Systems age, vendors patch unevenly, integrations change, and legacy platforms often sit beside newer cloud services. One recent NHIMG statistic highlights the scale of the problem: only 5.7% of organisations report full visibility into their service accounts, a useful reminder that many environments cannot reliably validate what they cannot fully see.

When validation is skipped, the organisation may still believe a control exists even though it has stopped matching current risk. That gap is especially dangerous in environments that carry PHI, support care delivery, or depend on fragile interoperability. NHI visibility and lifecycle discipline are part of that picture, because machine-facing access paths are easy to overlook during routine assurance.

Where the failure shows up in healthcare operations

Skipped validation usually shows up first as a confidence problem and then as an operational one. Controls that looked acceptable at design time may no longer protect the right assets, and compensating controls may be missing. In healthcare, that can leave EHR access paths, imaging systems, lab interfaces, or medical device networks exposed longer than teams realise.

The practical failure mode is stale assurance. A control can be documented, but not tested against present-day conditions such as changed identity scope, altered vendor connectivity, expired certificates, misrouted logs, or a monitoring rule that no longer fires. OWASP ASVS is a useful external reference point here because it treats verification as a concrete security requirement, not an assumption.

Healthcare organisations also tend to accumulate exceptions, temporary access, and legacy dependencies. Without validation, those exceptions become permanent. The result is not just weaker protection, but weaker evidence that the control environment is operating as designed, which is a problem when audits, investigations, or incident response need proof rather than policy.

Why validation failures become a governance problem, not just a technical one

Regular validation is the bridge between control design and control assurance. When that bridge is missing, governance teams cannot confidently say which safeguards are effective, which ones are degraded, and which ones should be remediated first. In healthcare, that undermines risk acceptance decisions, compliance reporting, and the ability to defend the organisation’s security posture after an incident.

That is why validation should be tied to the controls most likely to fail quietly: access enforcement, logging, backup recovery, segmentation, and secrets handling. External guidance such as the NIST SP 800-53 Rev. 5 Security and Privacy Controls is relevant because it gives teams a structured way to anchor validation in control families rather than ad hoc checks. NIST CSF 2.0 also helps by framing validation as part of ongoing govern, identify, protect, detect, respond, and recover activities.

Where machine-facing access is part of the environment, the governance risk increases further. Stale service credentials, broad access scopes, and weak revocation hygiene can keep a control looking healthy on paper while quietly expanding blast radius. The underlying lesson is simple: if a control is not routinely tested against the live environment, it cannot be treated as reliable evidence of protection.

Practitioner Guidance

What to prioritise: Validate controls that protect PHI, critical clinical workflows, remote access, privileged accounts, and medical device adjacencies first. These are the places where an undetected control gap creates the largest operational and reputational downside.

What to verify: Confirm that the control still covers the current asset inventory, current identity and access paths, current logging destinations, and current exception set. A control that only works for last quarter’s architecture is not a valid control.

Common mistake: Treating documentation review as validation. Evidence of a control should include observable function, such as test results, alert delivery, revocation behavior, or recovery confirmation, not just an approved policy.

Practitioner takeaway: In healthcare, skipped validation is dangerous because it creates a false sense of protection around systems that cannot tolerate silent drift, so the real objective is continuous assurance on the controls that carry the most patient, privacy, and operational impact.

Related resources from NHI Mgmt Group

• What happens when organisations depend on manual security testing instead of automated control validation?
• What happens when organisations skip validation before moving from prioritisation to mobilisation in CTEM?
• What happens when organisations try to reduce identity security spend without fixing control gaps?
• Should organisations treat agent audit logs as a security control?